MedTrace Logo

Gut Microbiome and Gestational Diabetes Mellitus

NCT02649374 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2019-09-12

No results posted yet for this study

Summary

The purpose of this study is to document the gut microbiome in the 1st, 2nd and 3rd trimester among pregnant women with gestational diabetes and non diabetic controls.

Conditions

  • Gestational Diabetes Mellitus

Interventions

BEHAVIORAL

Dietary, Exercise and lifestyle modifications

Women without GDM will receive advise on diet, exercise and lifestyle modifications similar to what is advised to women with GDM

Sponsors & Collaborators

  • Clalit Health Services

    collaborator OTHER

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Eran Hadar, MD · Rabin Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-12-10
Completion
2018-12-10

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02649374 on ClinicalTrials.gov